ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch

$TWST:NASDAQ · TWIST BIOSCIENCE CORP

Sector: health

Conviction from: NASDAQ

Tradable on: Bitget →

52-week range: 24.41219.71

3 tracked filer(s) hold this · 1 opened, 1 added, 1 trimmed in 30-SEP-2026

Aggregate 13FScore 64 — mean of 3 scored holder(s) · buyers (new/add) avg 65. Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Steve Cohen / Point7275New buy343,262$66,331,9490.1%
Bridgewater55Added +345%83,029$16,044,5240.1%
Paul Tudor Jones / Tudor61Trimmed -48%16,200$3,130,4880.0%

Beyond 13F — activists, insiders, politicians & research

Serenity (@aleabitoreddit) full tracker →

Watching · 1 mention(s), 0 personal-position post(s) · first 2026-11-07 · last 2026-11-07

“Even with current narratives like biotech eg. $TWST, there's 100%+ Y/Y growth from their AI testing segment with Anthropic. But if you look at company overall revenue projections, they're only calling for double revenue growth by 2031 (implying 15% annual growth). I'm sure they can beat, but this seems relatively slow compared to AI supply chains growing hundreds to 1000% Y/Y and seeing record…” post →

All 1 tweet(s) mentioning this ticker
DateTweet
2026-11-07T14:50:42Even with current narratives like biotech eg. $TWST, there's 100%+ Y/Y growth from their AI testing segment with Anthropic. But if you look at company overall revenue projections, they're only calling for double revenue growth by 2031 (implying 15% annual growth). I'm sure they can beat, but thi… → · 77 likes · 19,470 views

Citrini Research coverage report library →

ReportDateStance
#134 — Citrini Therapeutics: We Wanted to Use Claude to Create a New Drug2026-10-20WATCH
#124 — State of the Themes: June 20262026-06-01WATCH

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.